• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human NAD kinase (NADK)

ACP20657

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP20657 Target NameNADK
Target SynonymsdJ283E3.1; FLJ13052; FLJ37724; NAD kinase; Nadk; NADK_HUMAN; Poly(P)/ATP NAD kinase; PPNK; RP1-283E3.6FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-446
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO95544
Background Information
  • Uniprot Id

    O95544

  • Target Species

    Human

  • Target Name

    NADK

  • Target Full Name

    NAD kinase

  • Target Synonyms

    dJ283E3.1; FLJ13052; FLJ37724; NAD kinase; Nadk; NADK_HUMAN; Poly(P)/ATP NAD kinase; PPNK; RP1-283E3.6

  • Target Background

    NADK catalyzes the transfer of a phosphate group from ATP to NAD to generate NADP, which in its reduced form acts as an electron donor for biosynthetic reactions (Lerner et al., 2001 [PubMed 11594753]).

Inquire Recombinant Human NAD kinase (NADK) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification